← All trials
NCT00168545
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- —
- Completion date
- Jan 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 400
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Bandim Health ProjectLead sponsor
- Medical Research Council, The GambiaCollaborator
- Bandim Health ProjectStudy director
- Bandim Health ProjectOverall official - principal investigator
- Danish Council for Development ResearchCollaborator
- Novo NordiskCollaborator
- Leiden UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.